Rallybio Corp. (RLYB)
16.81
+0.05
(+0.30%)
USD |
NASDAQ |
Aug 28, 16:00
16.84
+0.03
(+0.18%)
After-Hours: 20:00
Rallybio Cash from Operations (Quarterly) : 45.92M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.92M |
| March 31, 2026 | -7.978M |
| December 31, 2025 | -4.679M |
| September 30, 2025 | -6.55M |
| June 30, 2025 | -8.379M |
| March 31, 2025 | -10.20M |
| December 31, 2024 | -9.862M |
| September 30, 2024 | -13.54M |
| June 30, 2024 | -10.42M |
| March 31, 2024 | -15.46M |
| December 31, 2023 | -11.64M |
| September 30, 2023 | -16.47M |
| June 30, 2023 | -13.38M |
| Date | Value |
|---|---|
| March 31, 2023 | -18.76M |
| December 31, 2022 | -15.26M |
| September 30, 2022 | -14.74M |
| June 30, 2022 | -13.55M |
| March 31, 2022 | -13.73M |
| December 31, 2021 | -9.886M |
| September 30, 2021 | -10.87M |
| June 30, 2021 | -12.85M |
| March 31, 2021 | -11.93M |
| December 31, 2020 | -7.261M |
| September 30, 2020 | -5.623M |
| June 30, 2020 | -3.616M |
| March 31, 2020 | -5.539M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Q32 Bio, Inc. | -3.075M |
| Beam Therapeutics, Inc. | -66.10M |
| C4 Therapeutics, Inc. | -1.574M |
| Cullinan Therapeutics, Inc. | -38.22M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 5.50M |
| Cash from Financing (Quarterly) | 0.131M |
| Free Cash Flow | 26.71M |
| Free Cash Flow Per Share (Quarterly) | 7.920 |
| Free Cash Flow to Equity (Quarterly) | 46.07M |
| Free Cash Flow to Firm (Quarterly) | 45.92M |
| Free Cash Flow Yield | 28.37% |